Development and validation of a nomogram for predicting rapid relapse in triple-negative breast cancer patients treated with neoadjuvant chemotherapy

Development and validation of a nomogram for predicting rapid relapse in triple-negative breast cancer patients treated with neoadjuvant chemotherapy

BackgroundTriple-negative breast cancer (TNBC) accounts for disproportionately poor outcomes in breast cancer, driven by a subset of rapid-relapse TNBC (rrTNBC) with marked chemoresistance, rapid metastatic spread, and poor survival. This study aimed to develop and validate a nomogram based on clini...

Full description

Bibliographic Details
Main Authors: Tao Ma, Xin-Yu Liu, Shuang-Long Cai, Jin Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-09-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
triple-negative breast cancer
neoadjuvant chemotherapy
rapid relapse
nomogram
predictive markers
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2024.1417366/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2024.1417366/full

Similar Items